Ian Andrew James - 29 Apr 2024 Form 4 Insider Report for Better For You Wellness, Inc. (BFYW)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Ian James
Issuer symbol
BFYW
Transactions as of
29 Apr 2024
Net transactions value
+$184
Form type
4
Filing time
03 May 2024, 17:30:44 UTC
Previous filing
29 Apr 2024
Next filing
10 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BFYW Common Stock Award $24 +15,000 +0.03% $0.001600* 56,359,849 29 Apr 2024 Direct F1
transaction BFYW Common Stock Award $32 +20,000 +0.04% $0.001600* 56,379,849 30 Apr 2024 Direct F2
transaction BFYW Common Stock Award $128 +75,000 +0.13% $0.001700* 56,447,849 02 May 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.00145 to $0.0017. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, complete information regarding the number of shares purchased at each separate price within the range outlined in this footnote.
F2 The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.00155 to $0.0017. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, complete information regarding the number of shares purchased at each separate price within the range outlined in this footnote.
F3 The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.0014 to $0.0024. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, complete information regarding the number of shares purchased at each separate price within the range outlined in this footnote.